News + Press

04.05.2024 |

Identifying Biomarkers for Visual Restoration Strategies in NF1-OPGs

04.05.2024 |

A Phase 3 Randomized Study of Selumetinib versus Carboplatin and Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)

04.05.2024 |

Vision Restoration in Neurofibromatosis – Donor RGC Response to Microenvironment

04.05.2024 |

Stem Cell Derived RGCs – Improving the Success of Transplantation Strategies – Phase B

04.05.2024 |

Neuroprotection and Optic Nerve Regeneration in a Mouse NF1 OPG Model – Phase B

04.05.2024 |

NF1-OPG Pig Model Development

04.05.2024 |

Axon Regeneration and Vision Restoration in NF1-OPG – Phase B

04.05.2024 |

RGC Differentiation and Transplantation for NF1-OPG – Phase B

04.05.2024 |

Human iPSC-derived Reporter Lines for Optic Nerve Remyelination Research in NF1

04.05.2024 |

Generation and Neuroprotective Studies of NF1 Patient-derived RGCs – Phase B